Recently, Sun and colleagues demonstrated that CD93 interacting with its receptor insulin-like growth factor binding protein 7 (IGFBP7) could contribute to abnormal tumor vasculature in human umbilical vein endothelial cells and influence tumor growth in in vitro murine KPC model (7). This evidence concerns the gene CD93 and neoplasm.